Novavax is pulling out of its Covid-19 vaccine deal with Gavi, the Vaccine Alliance, a global partnership tasked with ensuring vaccine access in lower-income countries, following an alleged contract violation.
The Maryland-based company claimed on Friday that Gavi failed to purchase at least 350 million doses of its protein-based vaccine Nuvaxovid by the end of the year, per an advanced purchase agreement. Gavi, the World Health Organization and the Coalition for Epidemic Preparedness Innovations (CEPI) are co-leaders of COVAX, an effort to ensure that all participating countries, regardless of income levels, have access to vaccines.
Gavi paid Novavax $350 million last year and another $350 million in early 2022 as part of the agreement, according to the company’s Q1 report. However, Novavax said it has only received orders for 2 million doses from Gavi this year.
While Gavi was not immediately available for comment, the organization has reportedly denied a…
Click here to view original post